Predict falls using wearable technology

Trial ID
NCT07281755
Official Title
Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
Goal
Predict falls using wearable technology
Status
RECRUITING
Sponsor
Northumbria University
Study Type
OBSERVATIONAL
Enrollment
60 participants
Conditions
Parkinson Disease(PD)

Plain-Language Summary

The team wants to validate wearable sensors that provide objective mobility measures and use those signals to predict falls in people with Parkinson's. Participants will wear small body sensors that record walking patterns, turns, balance and daily activity both in clinic tests and at home, and researchers will build and test algorithms that translate gait speed, step variability and sway into mobility scores and fall risk predictions. As an observational project, it does not change medications but records movement while people use their usual treatments. They are enrolling about 60 people age 50 and up with a Parkinson's diagnosis by a movement disorder specialist using UK Brain Bank criteria, Hoehn and Yahr stages I to III, MoCA score 21 or higher, able to stand and walk unassisted for two minutes, with no other neurological disorders or recent lower limb injury, and who can attend visits in Newcastle upon Tyne.

Locations

  • Northumbria University, Newcastle upon Tyne, United Kingdom

Frequently Asked Questions

What is this trial testing?
This trial is studying an experimental treatment. The team wants to validate wearable sensors that provide objective mobility measures and use those signals to predict falls in people with Parkinson's. Participants will wear small body sensors that record walking patterns, turns, balance and daily activity both in clinic tests and at home, and researchers will build and test algorithms that translate gait speed, step variability and sway into mobility scores and fall risk predictions. As an observational project, it does not change medications but records movement while people use their usual treatments. They are enrolling about 60 people age 50 and up with a Parkinson's diagnosis by a movement disorder specialist using UK Brain Bank criteria, Hoehn and Yahr stages I to III, MoCA score 21 or higher, able to stand and walk unassisted for two minutes, with no other neurological disorders or recent lower limb injury, and who can attend visits in Newcastle upon Tyne.
Who can participate?
Participants must be at least 50 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 2 years and 1 month.

View on ClinicalTrials.gov